» Articles » PMID: 17713821

Histological Aggressiveness of Fluorodeoxyglucose Positron-emission Tomogram (FDG-PET)-detected Incidental Thyroid Carcinomas

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2007 Aug 24
PMID 17713821
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We previously reported a high incidence of primary thyroid cancer in fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid abnormalities. The aim of our study was to determine if these FDG-PET-detected thyroid malignancies represent a more-aggressive variant of primary thyroid carcinoma.

Materials And Methods: All patients that underwent operative intervention for FDG-PET-detected incidental thyroid abnormalities were identified (June 2003 to April 2006). Patients with a diagnosis of primary thyroid carcinoma on final histopathology were included in the study. The patient demographics and histopathological findings were analyzed to identify adverse prognostic features.

Results: In 11,500 patients, 17,250 FDG-PET scans were performed; 377 of these patients (3.2% of patients and 2.1% of FDG-PET scans) had findings positive for thyroid abnormality. Of the 32 patients that underwent operative intervention, 22 patients with a final diagnosis of primary thyroid malignancy were included in the study. A greater number of patients [12 patients, (54%)] were noted to harbor poor prognostic variants of primary thyroid carcinoma on final histopathology [tall-cell variant: 11 patients (50%) and poorly differentiated thyroid carcinoma: 1 patient (4%)]. Extra-thyroidal extension (ETE) was noted in the majority of patients [14 patients (63%)]. In patients with tall cell variant on final histopathology, the rate of ETE was even higher [10 patients (90%)].

Conclusion: Thyroid malignancies incidentally detected on FDG-PET scan harbor a high rate of unfavorable prognostic features and may represent a more-aggressive variant of primary thyroid carcinoma. These patients need to be subjected to further investigation with a view to possible operative intervention.

Citing Articles

Enhanced staging of differentiated thyroid carcinoma: integrating [F]FDG digital PET/CT with neck ultrasound.

Piccardo A, Bottoni G, Treglia G, Foppiani L, Mariani F, Catrambone U Eur J Nucl Med Mol Imaging. 2025; .

PMID: 39998675 DOI: 10.1007/s00259-025-07169-3.


Tumor Microenvironment Features as Predictive Biomarkers in Metastatic Differentiated Thyroid Cancer and Their Relationship With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Metabolic Parameters.

Soyluoglu S, Tastekin E, Andac B, Korkmaz U, Orun S, Durmus Altun G Cureus. 2023; 15(9):e44751.

PMID: 37809246 PMC: 10556374. DOI: 10.7759/cureus.44751.


MANAGEMENT PRINCIPLES OF INCIDENTAL THYROID 18F-FDG UPTAKE IDENTIFIED ON 18F-FDG PET/CT IMAGING.

Akbas A, Dagmura H, Gul S, Dasiran F, Daldal E, Okan I Acta Endocrinol (Buchar). 2022; 18(2):253-257.

PMID: 36212269 PMC: 9512372. DOI: 10.4183/aeb.2022.253.


The dilemma of F-FDG PET/CT thyroid incidentaloma: what we should expect from FNA. A systematic review and meta-analysis.

Scappaticcio L, Piccardo A, Treglia G, Poller D, Trimboli P Endocrine. 2021; 73(3):540-549.

PMID: 33761104 PMC: 8325664. DOI: 10.1007/s12020-021-02683-4.


EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy.

Giovanella L, Avram A, Iakovou I, Kwak J, Lawson S, Lulaj E Eur J Nucl Med Mol Imaging. 2019; 46(12):2514-2525.

PMID: 31392371 DOI: 10.1007/s00259-019-04472-8.